Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer

Lanxiang Huang(Zhongnan Hospital of Wuhan University), Fubing Wang(Zhongnan Hospital of Wuhan University)
Molecular Cancer
February 11, 2022
Cited by 386


Related Papers